The development of a complementary tool that allows direct, sensitive, and label-free monitoring of albumin secretion in hepatocyte cell culture can provide insight into NAFLD’s mechanism and drug action. Here, ALB is linked to metabolic dysfunction-associated steatotic liver disease.